We are presenting exciting progress about MTHFD1/2 inhibitors at BIO International in Boston

by admin
maj 25, 2023

You can listen to our company presentation on Monday, June 5 and during the 12th International Cancer Cluster Showcase satellite symposium at BIO.

Rekommenderade artiklar

Dr Eva Ehrnrooth, MD PhD to join One-carbon Therapeutics AB management team as interim CMO

Dr Eva Ehrnrooth (MD PhD) brings + 20 years of

One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe

One-carbon therapeutics AB is discussing the ODIN trial with several

Our Founder Prof Thomas Helleday wins the Anders Jahre’s price in Medicine

Read the article here.

Menu bar